<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="50150">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02453334</url>
  </required_header>
  <id_info>
    <org_study_id>1VIT14039</org_study_id>
    <nct_id>NCT02453334</nct_id>
  </id_info>
  <brief_title>Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®</brief_title>
  <acronym>IRON CLAD</acronym>
  <official_title>IRON CLAD: Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Multi-center, Randomized, Double-blinded, Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose Injection)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Luitpold Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Luitpold Pharmaceuticals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phase III, multicenter, randomized, double-blinded, prospective study with two parallel
      treatment groups. Patients who present to the hematologist/oncologist and satisfy all
      inclusion and exclusion criteria will be eligible for participation in this 18-week study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a Phase III, multicenter, randomized, double-blinded, prospective study with two
      parallel treatment groups. Patients who present to the hematologist/oncologist and satisfy
      all inclusion and exclusion criteria will be eligible for participation in this 18-week
      study. Subjects who meet all inclusion criteria and no exclusion criteria, will be
      randomized into the trial (Group A or B).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant, Care Provider, Investigator, Outcomes Assessor</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients with a decrease in Hgb ≥ 0.5 g/dL from baseline to Week 18</measure>
    <time_frame>Baseline to Week 18</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Cancer and Chemotherapy Related Anemia</condition>
  <arm_group>
    <arm_group_label>Injectafer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 doses of Injectafer at 15mg/kg for a maximum single dose of 750mg given 7 days apart for a total of up to 1500mg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline administered as an infusion of no more than 250mL infused over 15 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Injectafer</intervention_name>
    <arm_group_label>Injectafer</arm_group_label>
    <other_name>ferric carboxymaltose injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <arm_group_label>Normal Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects (male of female) ≥ 18 years of age able to give informed consent to the
             study.

          -  Subjects with non-myeloid malignancies

          -  Receiving chemotherapy as part of their cancer treatment with at least 4 weeks of
             treatment remaining.

          -  Screening visit central laboratory hemoglobin (Hgb) ≤11 g/dL, but ≥8 g/dL.

          -  Ferritin between 100 and 800 ng/mL and transferrin saturation (TSAT) =&lt;35%

          -  Subjects must have Eastern Coopertative Oncology Group (ECOG) performance status of
             0-2.

          -  Life expectancy of at least 6 months.

          -  Demonstrate the ability to understand the requirements of the study, willingness to
             abide by study restrictions and to return for the required assessments.

        Exclusion Criteria:

          -  Previous participation in a ferric carboxymaltose clinical trial.

          -  Known hypersensitivity reaction to any component of ferric carboxymaltose.

          -  Subjects with overt bleeding

          -  Any anemia treatment within 4 weeks before inclusion (oral iron, IV iron,
             transfusion, or erythropoiesis-stimulating agents).

          -  Subjects on erythropoiesis-stimulating agents.

          -  Requiring dialysis for the treatment of chronic kidney disease.

          -  Any non-viral infection.

          -  Known positive hepatitis with evidence of active disease.

          -  Received an investigational drug within 30 days of screening.

          -  Alcohol or drug abuse within the past 6 months.

          -  Hemochromatosis or other iron storage disorders.

          -  Any other laboratory abnormality, medical condition or psychiatric disorders which in
             the opinion of the Investigator would put the subject's disease management at risk or
             may result in the subject being unable to comply with study requirements.

          -  Pregnant or actively trying to become pregnant (Female subjects who are of
             childbearing age must have a negative pregnancy test at screening and be practicing
             an acceptable method of birth control during the study).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Todd Koch</last_name>
    <phone>610-650-4200</phone>
    <email>tkoch@lpicrd.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sumita Chowdhury, MD, MPH</last_name>
    <phone>610-650-4200</phone>
    <email>SChowdhury@lpicrd.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Compassionate Care Research Group, Inc.</name>
      <address>
        <city>Corona</city>
        <state>California</state>
        <zip>92879</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Raowas, M.D.</last_name>
      <phone>714-698-0303</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Compassionate Care Research Group, Inc.</name>
      <address>
        <city>Fountain Valley</city>
        <state>California</state>
        <zip>92708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haresh S. Jhangiani, MD FACP MBA</last_name>
      <phone>714-698-0300</phone>
    </contact>
    <contact_backup>
      <last_name>Barbara Lepthien, CRC</last_name>
      <email>barbaral@compcareresearch.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Compassionate Care Research Group, Inc.</name>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <zip>92501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian Choi, M.D.</last_name>
      <phone>951-276-2760</phone>
    </contact>
    <contact_backup>
      <last_name>Corina King, CRC</last_name>
      <email>cking@compcareresearch.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University Cancer Institute</name>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <zip>33426</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas M.J. Niederman, M.D., Ph.D.</last_name>
    </contact>
    <contact_backup>
      <last_name>Tom Voulgaris</last_name>
      <phone>561-737-6556</phone>
      <email>tvoulgaris@universitycancerinstitute.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>AR Development Solutions</name>
      <address>
        <city>Miami Lakes</city>
        <state>Florida</state>
        <zip>33014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giralt Yanez, M.D.</last_name>
      <phone>786-615-0780</phone>
    </contact>
    <contact_backup>
      <last_name>Anabel Daniel</last_name>
      <email>adaniel@ardsclinicaltrials.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Lakes Research</name>
      <address>
        <city>Miami Lakes</city>
        <state>Florida</state>
        <zip>33014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eloy Roman, M.D.</last_name>
      <phone>786-362-5763</phone>
    </contact>
    <contact_backup>
      <last_name>Yamile Sanchez, MBA</last_name>
      <email>ysanchez@lakesresearch.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>H. Lee Moffitt Cancer Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Jaglal, M.D.</last_name>
      <phone>813-844-8712</phone>
    </contact>
    <contact_backup>
      <last_name>Erika Silverman, RN</last_name>
      <email>esilverman@tgh.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Bond Bond Clinic, P.A.</name>
      <address>
        <city>Winter Haven</city>
        <state>Florida</state>
        <zip>33880</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Osama A. Hlalah, M.D.</last_name>
      <phone>863-293-1191</phone>
      <phone_ext>3391</phone_ext>
    </contact>
    <contact_backup>
      <last_name>Natalie Ford, RN</last_name>
      <email>nford@bondclinic.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Joliet Oncology Hematology Associates</name>
      <address>
        <city>Joliet</city>
        <state>Illinois</state>
        <zip>60435</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason JG Suh, M.D.</last_name>
      <phone>815-730-3098</phone>
    </contact>
    <contact_backup>
      <last_name>Dipti Tambe</last_name>
      <email>dtambe@jolietoncology.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>MId-Illinois Hematology &amp; Oncology Associates, Ltd.</name>
      <address>
        <city>Normal</city>
        <state>Illinois</state>
        <zip>61761</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Migas, M.D.</last_name>
      <phone>305-452-9701</phone>
      <phone_ext>207</phone_ext>
    </contact>
    <contact_backup>
      <last_name>Jodi Hall, RN</last_name>
      <email>jodi.hall@mihoaonline.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>OSF Saint Anthony Medical Center for Cancer Care</name>
      <address>
        <city>Rockford</city>
        <state>Illinois</state>
        <zip>61108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shylendra Sreenivasappa, M.D.</last_name>
      <phone>815-227-2674</phone>
    </contact>
    <contact_backup>
      <last_name>Mark Rogers, CCRC</last_name>
      <email>mark.w.rogers@osfhealthcare.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Michiana Hematology Oncology, PC</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46628</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo Braun, M.D.</last_name>
      <phone>574-234-6485</phone>
    </contact>
    <contact_backup>
      <last_name>Sharon Smith, RN, OCN</last_name>
      <email>sksmith@mhopc.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Northern Indiana Cancer Research Consortium</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46628</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo Braun, M.D.</last_name>
    </contact>
    <contact_backup>
      <last_name>Sharon Smith, RN,OCN</last_name>
      <email>sksmith@mhopc.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ashland-Bellefonte Cancer Center</name>
      <address>
        <city>Ashland</city>
        <state>Kentucky</state>
        <zip>41101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kirti K Jain, M.D.</last_name>
      <phone>606-836-0202</phone>
    </contact>
    <contact_backup>
      <last_name>Asheesh Jain</last_name>
      <email>asheesh@abcc.us</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Rcca Md, Llc</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralph V Boccia, M.D.</last_name>
      <phone>240-482-0556</phone>
    </contact>
    <contact_backup>
      <last_name>Jennifer Cipriano</last_name>
      <email>jcipriano@ccbdmd.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Antietam Oncology and Hematology Group, P.C.</name>
      <address>
        <city>Hagerstown</city>
        <state>Maryland</state>
        <zip>21740</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hind F Hamdan, M.D.</last_name>
      <phone>301-797-8279</phone>
    </contact>
    <contact_backup>
      <last_name>Ami Rowe, CRNP</last_name>
      <email>amirowe@myactv.net</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>North Mississippi and Oncology Associates</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <zip>38801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julian B. HIll, M.D.</last_name>
      <phone>662-377-4629</phone>
    </contact>
    <contact_backup>
      <last_name>Marthe Thomas, RN BSN CCRC</last_name>
      <email>mmthomas@nmhs.net</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>East Chester Cancer Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10469</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabio Volterra, M.D.</last_name>
      <phone>718-732-4029</phone>
    </contact>
    <contact_backup>
      <last_name>Karen Hoffman, M.D.</last_name>
      <email>karen@eastchestercenter.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Brookdale University Hospital and Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jen C Wang, MD</last_name>
      <phone>718-240-5807</phone>
    </contact>
    <contact_backup>
      <last_name>Magdy Remyes, MD</last_name>
      <email>mremyes@bhmcny.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Waverly Hematology Oncology</name>
      <address>
        <city>Cary</city>
        <state>North Carolina</state>
        <zip>27518</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark L. Graham, M.D Ph.D.</last_name>
      <phone>919-223-8566</phone>
    </contact>
    <contact_backup>
      <last_name>Lindsay Debinder</last_name>
      <email>ldebinder@waverlyhemeonc.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Kinston Medical Specialists</name>
      <address>
        <city>Kinston</city>
        <state>North Carolina</state>
        <zip>28501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter R Watson, M.D.</last_name>
      <phone>252-559-2200</phone>
    </contact>
    <contact_backup>
      <last_name>JoAnne Moye</last_name>
      <email>jmoye14@yahoo.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Gettysburg Cancer Center</name>
      <address>
        <city>Gettysburg</city>
        <state>Pennsylvania</state>
        <zip>17325</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tina A Khair, D.O.</last_name>
      <phone>717-334-5599</phone>
    </contact>
    <contact_backup>
      <last_name>Vanessa Hardman</last_name>
      <email>vhardman@gettysburgoncology.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Charleston Hematology/Oncology Associates, P.A.</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29414</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James M. Orcutt, M.D.</last_name>
      <phone>843-266-0694</phone>
    </contact>
    <contact_backup>
      <last_name>Stephanie Patel, RN</last_name>
      <email>stephanie.patel@choasc.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Westchase Clinical Associates</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tannaz Armaghany, MD</last_name>
      <phone>713-523-6700</phone>
    </contact>
    <contact_backup>
      <last_name>Marjan Asadifard, MD</last_name>
      <email>masa@westcca.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 27, 2017</lastchanged_date>
  <firstreceived_date>May 21, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ferric Compounds</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
